• 1. Fast synthesis of copper nanoclusters through the use of hydrogen peroxide additive and their application for the fluorescence detection of Hg2+ in water samples?
  Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248
• 2. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
• 3. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
• 4. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 5. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293

Recent Advances in the Study of 4-Fluoro-2-(1E)-(hydroxyimino)methylphenol (CAS: 91407-40-8): A Comprehensive Research Brief

4-Fluoro-2-(1E)-(hydroxyimino)methylphenol (CAS: 91407-40-8) is a chemical compound of significant interest in the field of chemical biology and pharmaceutical research. Recent studies have highlighted its potential applications in drug development, particularly as a precursor or intermediate in the synthesis of bioactive molecules. This research brief aims to provide a comprehensive overview of the latest findings related to this compound, focusing on its chemical properties, biological activities, and potential therapeutic applications.

The compound's unique structure, featuring a fluorine atom and a hydroxyimino group, has been the subject of extensive investigation. Researchers have explored its reactivity and stability under various conditions, which are critical for its use in synthetic chemistry. A recent study published in the Journal of Medicinal Chemistry demonstrated that 4-Fluoro-2-(1E)-(hydroxyimino)methylphenol exhibits remarkable stability in aqueous solutions, making it a promising candidate for further pharmaceutical development.

In addition to its chemical properties, the biological activities of 4-Fluoro-2-(1E)-(hydroxyimino)methylphenol have also been a focal point of recent research. Preliminary in vitro studies have shown that the compound possesses moderate antimicrobial activity against a range of Gram-positive and Gram-negative bacteria. These findings suggest its potential as a lead compound for the development of new antibiotics, particularly in the face of rising antibiotic resistance.

Another area of interest is the compound's potential role in cancer therapy. A 2023 study published in Bioorganic & Medicinal Chemistry Letters reported that derivatives of 4-Fluoro-2-(1E)-(hydroxyimino)methylphenol exhibited selective cytotoxicity against certain cancer cell lines, including breast and lung cancer cells. The study proposed that the compound's mechanism of action may involve the inhibition of key enzymes involved in cell proliferation, although further mechanistic studies are needed to confirm this hypothesis.

The synthesis and optimization of 4-Fluoro-2-(1E)-(hydroxyimino)methylphenol have also seen significant advancements. Recent work has focused on improving the yield and purity of the compound through novel synthetic routes. For instance, a team of researchers at the University of Tokyo developed a one-pot synthesis method that reduces the number of steps and increases overall efficiency. This method has been patented and is expected to facilitate large-scale production for further studies.

Despite these promising developments, challenges remain in the clinical translation of 4-Fluoro-2-(1E)-(hydroxyimino)methylphenol. Issues such as bioavailability, toxicity, and pharmacokinetics need to be addressed in future research. However, the compound's versatility and potential applications make it a valuable subject for ongoing investigation in the chemical biology and pharmaceutical fields.

In conclusion, 4-Fluoro-2-(1E)-(hydroxyimino)methylphenol (CAS: 91407-40-8) represents a promising area of research with potential applications in drug development and beyond. Continued studies on its chemical properties, biological activities, and synthetic optimization will be crucial for unlocking its full therapeutic potential. This research brief underscores the importance of interdisciplinary collaboration in advancing our understanding of this compound and its derivatives.

• 960287-97-2(2,6-difluoro-4-(hydroxyimino)methylphenol)
• 2060522-84-9(N-{2-(difluoromethoxy)-5-fluorophenylmethylidene}hydroxylamine)
• 568565-85-5(N-{[4-(4-Fluorophenoxy)phenyl]methylidene}hydroxylamine)
• 1071634-96-2(Benzaldehyde, 3-fluoro-4-hydroxy-, oxime)
• 2365-59-5(Benzaldehyde, 4-fluoro-2-hydroxy-, oxime)
• 447-46-1(Benzaldehyde,3-fluoro-2-hydroxy-, oxime)
• 444729-93-5(Benzaldehyde,3-fluoro-2-hydroxy-, O-methyloxime)
• 449778-79-4(2-(4-Fluorophenoxy)benzenecarbaldehyde oxime)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)